Researchers with the FDA’s Office of Prescription Drug Promotion (OPDP) announced plans for two new studies Sept. 23 on endorser status and actual use in Direct-to-Consumer television ads and perceptions of prescription drug products with medication tracking capabilities. The endorser status study complements a study started in 2020 that examined four endorser types in print ... Read More